Gene Therapy Approach for Intervertebral Disc Degeneration: An Update

Intervertebral disc degeneration is the primary cause of back pain and associated with neurological disorders including radiculopathy, myelopathy, and paralysis. The currently available surgical treatments predominantly include the excision of pathological discs, resulting in the function loss, immo...

Full description

Bibliographic Details
Main Authors: Yoshiki Takeoka, Takashi Yurube, Kotaro Nishida
Format: Article
Language:English
Published: Korean Spinal Neurosurgery Society 2020-03-01
Series:Neurospine
Subjects:
Online Access:http://www.e-neurospine.org/upload/pdf/ns-2040042-021.pdf
_version_ 1797334936612503552
author Yoshiki Takeoka
Takashi Yurube
Kotaro Nishida
author_facet Yoshiki Takeoka
Takashi Yurube
Kotaro Nishida
author_sort Yoshiki Takeoka
collection DOAJ
description Intervertebral disc degeneration is the primary cause of back pain and associated with neurological disorders including radiculopathy, myelopathy, and paralysis. The currently available surgical treatments predominantly include the excision of pathological discs, resulting in the function loss, immobilization, and potential additional complications due to the altered biomechanics. Gene therapy approach involves gene transfer into cells, affects RNA and protein synthesis of the encoded genes in the recipient cells, and facilitates biological treatment. Relatively long-exerting therapeutic effects by gene therapy are potentially advantageous to treat slow progressive degenerative disc disease. In gene therapy, the delivery method and selection of target gene(s) are essential. Although gene therapy was first mediated by viral vectors, technological progress has enabled to apply nonviral vectors and polyplex micelles for the disc. While RNA interference successfully provides specific downregulation of multiple genes in the disc, clustered regularly interspaced short palindromic repeats (CRISPR) system has increased attention to alter the process of intervertebral disc degeneration. Then, more recent findings of our studies have suggested autophagy, the intracellular self-digestion, and recycling system under the negative regulation by the mammalian target of rapamycin (mTOR), as a gene therapy target in the disc. Here we briefly review backgrounds and applications of gene therapy for the disc, introducing strategies of autophagy and mTOR signaling modulation through selective RNA interference.
first_indexed 2024-03-08T08:29:30Z
format Article
id doaj.art-758243d9ab4f4b01b5a97f1c561e60f6
institution Directory Open Access Journal
issn 2586-6583
2586-6591
language English
last_indexed 2024-03-08T08:29:30Z
publishDate 2020-03-01
publisher Korean Spinal Neurosurgery Society
record_format Article
series Neurospine
spelling doaj.art-758243d9ab4f4b01b5a97f1c561e60f62024-02-02T03:49:10ZengKorean Spinal Neurosurgery SocietyNeurospine2586-65832586-65912020-03-0117131410.14245/ns.2040042.021973Gene Therapy Approach for Intervertebral Disc Degeneration: An UpdateYoshiki Takeoka0Takashi Yurube1Kotaro Nishida2 Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, JapanIntervertebral disc degeneration is the primary cause of back pain and associated with neurological disorders including radiculopathy, myelopathy, and paralysis. The currently available surgical treatments predominantly include the excision of pathological discs, resulting in the function loss, immobilization, and potential additional complications due to the altered biomechanics. Gene therapy approach involves gene transfer into cells, affects RNA and protein synthesis of the encoded genes in the recipient cells, and facilitates biological treatment. Relatively long-exerting therapeutic effects by gene therapy are potentially advantageous to treat slow progressive degenerative disc disease. In gene therapy, the delivery method and selection of target gene(s) are essential. Although gene therapy was first mediated by viral vectors, technological progress has enabled to apply nonviral vectors and polyplex micelles for the disc. While RNA interference successfully provides specific downregulation of multiple genes in the disc, clustered regularly interspaced short palindromic repeats (CRISPR) system has increased attention to alter the process of intervertebral disc degeneration. Then, more recent findings of our studies have suggested autophagy, the intracellular self-digestion, and recycling system under the negative regulation by the mammalian target of rapamycin (mTOR), as a gene therapy target in the disc. Here we briefly review backgrounds and applications of gene therapy for the disc, introducing strategies of autophagy and mTOR signaling modulation through selective RNA interference.http://www.e-neurospine.org/upload/pdf/ns-2040042-021.pdfgene therapyviral and nonviral vectorpolyplex micelleclustered regularly interspaced short palindromic repeatsautophagy and mammalian target of rapamycin signalingintervertebral disc degeneration and regeneration
spellingShingle Yoshiki Takeoka
Takashi Yurube
Kotaro Nishida
Gene Therapy Approach for Intervertebral Disc Degeneration: An Update
Neurospine
gene therapy
viral and nonviral vector
polyplex micelle
clustered regularly interspaced short palindromic repeats
autophagy and mammalian target of rapamycin signaling
intervertebral disc degeneration and regeneration
title Gene Therapy Approach for Intervertebral Disc Degeneration: An Update
title_full Gene Therapy Approach for Intervertebral Disc Degeneration: An Update
title_fullStr Gene Therapy Approach for Intervertebral Disc Degeneration: An Update
title_full_unstemmed Gene Therapy Approach for Intervertebral Disc Degeneration: An Update
title_short Gene Therapy Approach for Intervertebral Disc Degeneration: An Update
title_sort gene therapy approach for intervertebral disc degeneration an update
topic gene therapy
viral and nonviral vector
polyplex micelle
clustered regularly interspaced short palindromic repeats
autophagy and mammalian target of rapamycin signaling
intervertebral disc degeneration and regeneration
url http://www.e-neurospine.org/upload/pdf/ns-2040042-021.pdf
work_keys_str_mv AT yoshikitakeoka genetherapyapproachforintervertebraldiscdegenerationanupdate
AT takashiyurube genetherapyapproachforintervertebraldiscdegenerationanupdate
AT kotaronishida genetherapyapproachforintervertebraldiscdegenerationanupdate